Latest News about SRPT
Recent news which mentions SRPT
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
September 28, 2022
From Benzinga
$6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying
September 16, 2022
From Benzinga
A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%
September 08, 2022
Tickers
SRPT
From Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
September 06, 2022
Tickers
SRPT
From Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
August 29, 2022
From Motley Fool
Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications
August 08, 2022
Tickers
SRPT
From Benzinga
Sarepta Therapeutics (SRPT) Q2 2022 Earnings Call Transcript
August 02, 2022
Tickers
SRPT
From Motley Fool
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
From Benzinga
Chevron, Amazon And Some Other Big Gainers From Friday
August 01, 2022
From Benzinga
From Benzinga
Duchenne Gene Therapy Firm Sarepta Therapeutics' Earns 8% Price Target Hike From This Analyst
July 29, 2022
Tickers
SRPT
From Benzinga
From Benzinga
Exxon Mobil (XOM) Stock Pops on Record Profits
July 29, 2022
From InvestorPlace
CENN Stock Alert: Cenntro Invests in E-Cargo Designer
July 29, 2022
From InvestorPlace
From Benzinga
Sarepta (SRPT) Stock Gains on FDA News
July 29, 2022
From InvestorPlace
From Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 07, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.